Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of …
Natriuretic peptides, brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of
brain natriuretic peptide (NT-proBNP) are globally and most often used for the diagnosis of …
brain natriuretic peptide (NT-proBNP) are globally and most often used for the diagnosis of …
Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure
C Ronco, M Cicoira, PA McCullough - Journal of the American College of …, 2012 - jacc.org
Cardiorenal syndrome (CRS) type 1 is characterized as the development of acute kidney
injury (AKI) and dysfunction in the patient with acute cardiac illness, most commonly acute …
injury (AKI) and dysfunction in the patient with acute cardiac illness, most commonly acute …
[HTML][HTML] Effect of nesiritide in patients with acute decompensated heart failure
Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …
with acute heart failure. Previous meta-analyses have raised questions regarding renal …
Cardiorenal syndrome: new perspectives
JS Bock, SS Gottlieb - Circulation, 2010 - Am Heart Assoc
Maintenance of blood volume, vascular tone, and hemo-dynamic stability depends on a set
of elegant interactions between the heart and kidney. For some time, physicians have …
of elegant interactions between the heart and kidney. For some time, physicians have …
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the …
With a prevalence of 5 800 000 (2% of the entire populace) in 2009 and an estimated yearly
incidence of 550 000, the burden of heart failure (HF) in the United States is tremendous. 1 …
incidence of 550 000, the burden of heart failure (HF) in the United States is tremendous. 1 …
Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan …
H Yaku, N Ozasa, T Morimoto, Y Inuzuka… - Circulation …, 2018 - jstage.jst.go.jp
Background: There is a scarcity of reports on the clinical characteristics and management
practice in contemporary all-comer patients with acute decompensated heart failure (ADHF) …
practice in contemporary all-comer patients with acute decompensated heart failure (ADHF) …
Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND …
Objectives: This study sought to examine the relationships between in-hospital and post-
discharge body weight changes and outcomes among patients hospitalized for acute heart …
discharge body weight changes and outcomes among patients hospitalized for acute heart …
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates? Findings from ASCEND-HF
Background—Hospital readmission is an important clinical outcome of patients with heart
failure. Its relation to length of stay for the initial hospitalization is not clear. Methods and …
failure. Its relation to length of stay for the initial hospitalization is not clear. Methods and …
Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial
SJ Greene, AF Hernandez, A Dunning… - Journal of the American …, 2017 - jacc.org
Background: It is unclear how patients hospitalized for acute heart failure (HF) who are long-
term chronic HF survivors differ from those with more recent HF diagnoses. Objectives: The …
term chronic HF survivors differ from those with more recent HF diagnoses. Objectives: The …
Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial
BACKGROUND: Heart failure remains a global health burden, and patients hospitalized are
particularly at risk, but genetic associates for subsequent death or rehospitalization are still …
particularly at risk, but genetic associates for subsequent death or rehospitalization are still …